Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature.
| Image |  |
|---|---|
| Description | scientific article published on 10 January 2017 |
| Author/s |
author: Ellen Kapiteijn Sjoerd H van der Burg John B A G Haanen |
| Publication date | January 10, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |